|
1
|
Creamer P and Hochberg MC: Osteoarthritis.
Lancet. 350:503–508. 1997.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hunter DJ and Bierma-Zeinstra S:
Osteoarthritis. Lancet. 393:1745–1759. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Charlier E, Deroyer C, Ciregia F, Malaise
O, Neuville S, Plener Z, Malaise M and de Seny D: Chondrocyte
dedifferentiation and osteoarthritis (OA). Biochem Pharmacol.
165:49–65. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Şahin Ş, Tuncel SA, Salimi K, Bilgiç E,
Korkusuz P and Korkusuz F: Advanced injectable alternatives for
osteoarthritis. Adv Exp Med Biol. 1077:183–96. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ghouri A and Conaghan PG: Update on novel
pharmacological therapies for osteoarthritis. Ther Adv
Musculoskelet Dis. 11(1759720X19864492)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vinatier C, Merceron C and Guicheux J:
Osteoarthritis: From pathogenic mechanisms and recent clinical
developments to novel prospective therapeutic options. Drug Discov
Today. 21:1932–1937. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yao Q, Chen Y and Zhou X: The roles of
microRNAs in epigenetic regulation. Curr Opin Chem Biol. 51:11–17.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu C, Tian B, Qu X, Liu F, Tang T, Qin A,
Zhu Z and Dai K: MicroRNAs play a role in chondrogenesis and
osteoarthritis (review). Int J Mol Med. 34:13–23. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Malemud CJ: MicroRNAs and osteoarthritis.
Cells 7: pii. (E92)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen J and Wu X: MicroRNA-103 contributes
to osteoarthritis development by targeting Sox6. Biomed
Pharmacother. 118(109186)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen H, Yang J and Tan Z: Upregulation of
microRNA-9-5p inhibits apoptosis of chondrocytes through
downregulating Tnc in mice with osteoarthritis following tibial
plateau fracture. J Cell Physiol. 234:23326–23336. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhu H, Yan X, Zhang M, Ji F and Wang S:
miR-21-5p protects IL-1β-induced human chondrocytes from
degradation. J Orthop Surg Res. 14(118)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu J, Wang Z, Shan Y, Pan Y, Ma J and Jia
L: Long non-coding RNA HOTAIR promotes osteoarthritis progression
via miR-17-5p/FUT2/β-catenin axis. Cell Death Dis.
9(711)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yan KS, Lin CY, Liao TW, Peng CM, Lee SC,
Liu YJ, Chan WP and Chou RH: EZH2 in cancer progression and
potential application in cancer therapy: A friend or foe? Int J Mol
Sci. 18: pii(E1172)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yamagishi M and Uchimaru K: Targeting EZH2
in cancer therapy. Curr Opin Oncol. 29:375–381. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xu J, Wang Z, Lu W, Jiang H, Lu J, Qiu J
and Ye G: EZH2 promotes gastric cancer cells proliferation by
repressing p21 expression. Pathol Res Pract.
215(152374)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lui JC, Garrison P, Nguyen Q, Ad M,
Keembiyehetty C, Chen W, Jee YH, Landman E, Nilsson O, Barnes KM
and Baron J: EZH1 and EZH2 promote skeletal growth by repressing
inhibitors of chondrocyte proliferation and hypertrophy. Nat
Commun. 7(13685)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang FJ, Luo W and Lei GH: Role of HIF-1α
and HIF-2α in osteoarthritis. Joint Bone Spine. 82:144–147.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Musumeci G, Castrogiovanni P, Loreto C,
Castorina S, Pichler K and Weinberg AM: Post-traumatic caspase-3
expression in the adjacent areas of growth plate injury site: A
morphological study. Int J Mol Sci. 14:15767–15784. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Giunta S, Castorina A, Marzagalli R,
Szychlinska MA, Pichler K, Mobasheri A and Musumeci G: Ameliorative
effects of PACAP against cartilage degeneration. Morphological,
immunohistochemical and biochemical evidence from in vivo and in
vitro models of rat osteoarthritis. Int J Mol Sci. 16:5922–5944.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Musumeci G, Castrogiovanni P, Trovato FM,
Weinberg AM, Al-Wasiyah MK, Alqahtani MH and Mobasheri A:
Biomarkers of chondrocyte apoptosis and autophagy in
osteoarthritis. Int J Mol Sci. 16:20560–20575. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shi Y, Hu X, Cheng J, Zhang X, Zhao F, Shi
W, Ren B, Yu H, Yang P, Li Z, et al: A small molecule promotes
cartilage extracellular matrix generation and inhibits
osteoarthritis development. Nat Commun. 10(1914)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Szychlinska MA, Ravalli S and Musumeci G:
Pleiotropic effect of fibrates on senescence and autophagy in
osteoarthritis. EBioMedicine. 45:11–12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Szychlinska MA, Castrogiovanni P, Nsir H,
Di Rosa M, Guglielmino C, Parenti R, Calabrese G, Pricoco E,
Salvatorelli L, Magro G, et al: Engineered cartilage regeneration
from adipose tissue derived-mesenchymal stem cells: A
morphomolecular study on osteoblast, chondrocyte and apoptosis
evaluation. Exp Cell Res. 357:222–235. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Trachana V, Ntoumou E, Anastasopoulou L
and Tsezou A: Studying microRNAs in osteoarthritis: Critical
overview of different analytical approaches. Mech Ageing Dev.
171:15–23. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dellago H, Bobbili MR and Grillari J:
MicroRNA-17-5p: At the crossroads of cancer and aging-a
mini-review. Gerontology. 63:20–28. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu
X, Feng Y and Dai Z: MiR-17-5p modulates osteoblastic
differentiation and cell proliferation by targeting SMAD7 in
non-traumatic osteonecrosis. Exp Mol Med. 46(e107)2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L,
Chen L, Yao C, Lv W, Chang G, et al: miR-17-5p suppresses cell
proliferation and invasion by targeting ETV1 in triple-negative
breast cancer. BMC Cancer. 17(745)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhu Y, Gu J, Li Y, Peng C, Shi M, Wang X,
Wei G, Ge O, Wang D, Zhang B, et al: MiR-17-5p enhances pancreatic
cancer proliferation by altering cell cycle profiles via disruption
of RBL2/E2F4-repressing complexes. Cancer Lett. 412:59–68.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jin J, Sun Z, Yang F, Tang L, Chen W and
Guan X: miR-19b-3p inhibits breast cancer cell proliferation and
reverses saracatinib-resistance by regulating PI3K/Akt pathway.
Arch Biochem Biophys. 645:54–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li H, Miao D, Zhu Q, Huang J, Lu G and Xu
W: MicroRNA-17-5p contributes to osteoarthritis progression by
binding p62/SQSTM1. Exp Ther Med. 15:1789–1794. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Duan L, Duan D, Wei W, Sun Z, Xu H, Guo L
and Wu X: MiR-19b-3p attenuates IL-1β induced extracellular matrix
degradation and inflammatory injury in chondrocytes by targeting
GRK6. Mol Cell Biochem. 459:205–214. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Camilleri ET, Dudakovic A, Riester SM,
Galeano-Garces C, Paradise CR, Bradley EW, McGee-Lawrence ME, Im
HJ, Karperien M, Krych AJ, et al: Loss of histone methyltransferase
Ezh2 stimulates an osteogenic transcriptional program in
chondrocytes but does not affect cartilage development. J Biol
Chem. 293:19001–19011. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Stazi G, Zwergel C, Mai A and Valente S:
EZH2 inhibitors: A patent review (2014-2016). Expert Opin Ther Pat.
27:797–813. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang X, Hu B, Shen H, Zhou H, Xue X, Chen
Y, Chen S, Han Y, Yuan B, Zhao H, et al: Clinical and prognostic
relevance of EZH2 in breast cancer: A meta-analysis. Biomed
Pharmacother. 75:218–225. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chen L, Wu Y, Wu Y, Wang Y, Sun L and Li
F: The inhibition of EZH2 ameliorates osteoarthritis development
through the Wnt/β-catenin pathway. Sci Rep. 6(29176)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Trenkmann M, Brock M, Gay RE, Kolling C,
Speich R, Michel BA, Gay S and Huber LC: Expression and function of
EZH2 in synovial fibroblasts: epigenetic repression of the Wnt
inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis.
70:1482–1488. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115.
2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Moore BT and Xiao P: MiRNAs in bone
diseases. Microrna. 2:20–31. 2013.PubMed/NCBI View Article : Google Scholar
|
